サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/09 | 3,315 | 3,480 | 3,265 | 3,420 | +40 | +1.2% | 2,179,600 |
| 2025/06/06 | 3,515 | 3,595 | 3,350 | 3,380 | -140 | -4% | 2,283,700 |
| 2025/06/05 | 3,650 | 3,660 | 3,445 | 3,520 | -140 | -3.8% | 4,089,600 |
| 2025/06/04 | 3,370 | 3,805 | 3,340 | 3,660 | +290 | +8.6% | 9,996,200 |
| 2025/06/03 | 3,290 | 3,380 | 3,155 | 3,370 | +150 | +4.7% | 3,732,800 |
| 2025/06/02 | 2,901 | 3,275 | 2,850 | 3,220 | +205 | +6.8% | 6,287,900 |
| 2025/05/30 | 3,520 | 3,935 | 2,951 | 3,015 | -400 | -11.7% | 17,837,800 |
| 2025/05/29 | 3,390 | 3,430 | 3,300 | 3,415 | +40 | +1.2% | 2,321,500 |
| 2025/05/28 | 3,205 | 3,405 | 3,190 | 3,375 | +155 | +4.8% | 2,981,000 |
| 2025/05/27 | 3,320 | 3,335 | 3,120 | 3,220 | -50 | -1.5% | 2,292,100 |
| 2025/05/26 | 3,215 | 3,345 | 3,160 | 3,270 | +105 | +3.3% | 3,071,500 |
| 2025/05/23 | 3,275 | 3,315 | 3,115 | 3,165 | -115 | -3.5% | 2,449,500 |
| 2025/05/22 | 3,335 | 3,420 | 3,160 | 3,280 | -30 | -0.9% | 2,952,700 |
| 2025/05/21 | 3,480 | 3,495 | 3,230 | 3,310 | -165 | -4.7% | 5,614,900 |
| 2025/05/20 | 3,000 | 3,490 | 2,980 | 3,475 | +486 | +16.3% | 10,624,700 |
| 2025/05/19 | 2,644 | 2,990 | 2,636 | 2,989 | +316 | +11.8% | 8,319,900 |
| 2025/05/16 | 2,800 | 2,828 | 2,672 | 2,673 | -113 | -4.1% | 5,431,500 |
| 2025/05/15 | 2,697 | 2,799 | 2,633 | 2,786 | +116 | +4.3% | 5,930,700 |
| 2025/05/14 | 2,719 | 2,756 | 2,630 | 2,670 | -31 | -1.1% | 6,025,400 |
| 2025/05/13 | 2,438 | 2,705 | 2,397 | 2,701 | +292 | +12.1% | 10,065,700 |
| 2025/05/12 | 2,500 | 2,549 | 2,340 | 2,409 | -59 | -2.4% | 5,819,700 |
| 2025/05/09 | 2,280 | 2,490 | 2,273 | 2,468 | +176 | +7.7% | 7,477,600 |
| 2025/05/08 | 2,316 | 2,340 | 2,242 | 2,292 | -25 | -1.1% | 3,484,400 |
| 2025/05/07 | 2,349 | 2,482 | 2,303 | 2,317 | +18 | +0.8% | 7,329,500 |
| 2025/05/02 | 2,315 | 2,438 | 2,269 | 2,299 | -23 | -1% | 9,260,600 |
| 2025/05/01 | 2,000 | 2,350 | 2,000 | 2,322 | +325 | +16.3% | 9,770,100 |
| 2025/04/30 | 2,045 | 2,095 | 1,973 | 1,997 | -20 | -1% | 3,406,300 |
| 2025/04/28 | 2,080 | 2,091 | 1,982 | 2,017 | -55 | -2.7% | 3,657,300 |
| 2025/04/25 | 1,935 | 2,089 | 1,894 | 2,072 | +174 | +9.2% | 5,930,300 |
| 2025/04/24 | 1,988 | 2,039 | 1,874 | 1,898 | -190 | -9.1% | 7,020,400 |
| 2025/04/23 | 2,286 | 2,313 | 2,085 | 2,088 | -194 | -8.5% | 7,990,200 |
| 2025/04/22 | 2,228 | 2,327 | 2,211 | 2,282 | +4 | +0.2% | 5,720,700 |
| 2025/04/21 | 2,363 | 2,388 | 2,159 | 2,278 | -121 | -5% | 8,287,500 |
| 2025/04/18 | 2,272 | 2,478 | 2,234 | 2,399 | +144 | +6.4% | 10,592,100 |
| 2025/04/17 | 2,140 | 2,280 | 2,112 | 2,255 | +115 | +5.4% | 7,568,200 |
| 2025/04/16 | 2,180 | 2,185 | 2,079 | 2,140 | ±0 | ±0% | 4,740,100 |
| 2025/04/15 | 2,096 | 2,153 | 2,046 | 2,140 | +140 | +7% | 8,206,100 |
| 2025/04/14 | 1,847 | 2,086 | 1,815 | 2,000 | +195 | +10.8% | 8,612,800 |
| 2025/04/11 | 1,620 | 1,805 | 1,620 | 1,805 | +131 | +7.8% | 4,388,700 |
| 2025/04/10 | 1,713 | 1,717 | 1,614 | 1,674 | +128 | +8.3% | 3,007,000 |
| 2025/04/09 | 1,626 | 1,669 | 1,481 | 1,546 | -107 | -6.5% | 3,255,100 |
| 2025/04/08 | 1,579 | 1,653 | 1,563 | 1,653 | +265 | +19.1% | 2,844,300 |
| 2025/04/07 | 1,520 | 1,555 | 1,388 | 1,388 | -239 | -14.7% | 4,027,700 |
| 2025/04/04 | 1,680 | 1,766 | 1,583 | 1,627 | -51 | -3% | 4,774,300 |
| 2025/04/03 | 1,550 | 1,708 | 1,550 | 1,678 | +41 | +2.5% | 3,142,100 |
| 2025/04/02 | 1,644 | 1,659 | 1,567 | 1,637 | -30 | -1.8% | 3,256,600 |
| 2025/04/01 | 1,800 | 1,850 | 1,633 | 1,667 | +20 | +1.2% | 11,704,500 |
| 2025/03/31 | 1,602 | 1,695 | 1,567 | 1,647 | -8 | -0.5% | 3,407,600 |
| 2025/03/28 | 1,623 | 1,781 | 1,622 | 1,655 | +10 | +0.6% | 7,918,000 |
| 2025/03/27 | 1,630 | 1,686 | 1,620 | 1,645 | -21 | -1.3% | 6,672,400 |
51～
100
件表示中 / 2534件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 253,800円 | - | - | 0.00% | - | 117.56倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| ペプチド | 153,500円 | +5.0% | +1.5% | 0.00% | 13.14倍 | 3.69倍 |
|
東大発のペプチド創薬ベンチャーの雄。海外製薬大手との提携多数。買収で放射性医薬品に参入 |
| キッセイ薬 | 429,000円 | +3.6% | - | 2.80% | 14.46倍 | 0.85倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 633,000円 | +7.1% | -35.0% | 0.00% | 52.34倍 | 1.45倍 |
|
ＪＴ傘下。皮膚疾患や腎・透析、花粉症薬などアレルゲン領域に強み。塩野義製薬がＴＯＢ実施 |
| 科研薬 | 388,400円 | -6.4% | -71.8% | 4.89% | 43.26倍 | 0.97倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
市場注目の銘柄
チャート関連のコラム
